Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing
BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA DDM™ and MSK-IMPACT® powered with SOPHiA DDM™. Thirty-seven prominent institutions, including top researchers and key opinion leaders worldwide, have already adopted the recently launched Liquid Biopsy and Solid Tumor applications.
Professor Umberto Malapelle, Chair of the Predictive Molecular Pathology Laboratory at the Department of Public Health of the University Federico II of Naples, Italy and the Scientific Secretary of the International Society of Liquid Biopsy, championed the new applications to support his research on lung and other cancers.
"When I learned SOPHiA GENETICS was offering applications from MSK on the SOPHiA DDM™ platform, I was really interested in the evaluation of the performance of this test, in particular because I see SOPHiA GENETICS as true collaborators to help pave the way for the future of cancer research," said Professor Malapelle.
"Bringing best-in-class technology to global organizations is crucial to help advance better health care for all. We are proud to work with trailblazers like Professor Malapelle, who are utilizing our technology and the collective power of our network to make strides in the next wave of cancer care," said Ross Muken, President, SOPHiA GENETICS.
Of the thirty-seven institutions adopting MSK solutions, thirty-four have signed on to adopt MSK-ACCESS® powered with SOPHiA DDM™, just ten months after the Liquid Biopsy application's launch. The decentralized deployment of MSK-ACCESS® has enabled hospitals and labs across the globe to launch world-renowned Liquid Biopsy testing from within the walls of their own institution, providing patients with a less-invasive option for genomic testing. In many cases, this decentralized testing also results in lower costs and faster turnaround times, while also enabling institutions to retain control of their patients' data for research or other purposes.
Internationally recognized organizations adopting the application include: Heidelberg University Hospital in Germany; Biopticka Laboratory in the Czech Republic; Hospital del Mar and Hospital La Fe in Spain; University Hospital of Nice and Marseille Regional Hospital Center in France; and Jewish General Hospital in Canada.
The complementary solid tumor application, MSK-IMPACT® powered with SOPHiA DDM™, has also attracted significant interest from leading organizations across the globe, including: the Jiménez Díaz Foundation University Hospital in Spain; the Cyprus Institute of Neurology and Genetics in Cyprus; and Sofiva Genomics in Taiwan.
Memorial Sloan Kettering Cancer Center (MSK) and SOPHiA GENETICS partnered in 2023 with a vision to use the sophisticated technology of the SOPHiA DDM™ Platform to bring MSK's state-of-the-art cancer testing capabilities to precision medicine institutions worldwide. The two leaders launched the Liquid Biopsy test MSK-ACCESS® powered with SOPHiA DDM™ in April 2024. In October 2024, SOPHiA GENETICS announced a definitive partnership agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to accelerate the deployment of MSK-ACCESS® powered with SOPHiA DDM™, aiming to increase the availability of this innovative Liquid Biopsy solution worldwide. In November 2024, SOPHiA GENETICS announced the launch of the complementary Solid Tumor test, MSK-IMPACT® powered with SOPHiA DDM™. These collaborations have the potential to transform cancer research as they enable healthcare providers to draw from a continuously evolving base of real-world data and gain insights from diverse populations while using best-in-class technology.
Join us on Tuesday, February 25, 2025, at 11:00 a.m. (11:00) EDT / 5:00 p.m. (17:00) CET for the Precision Oncology Showcase, a virtual webinar which will spotlight the transformative potential of decentralized, AI-driven technologies for the advancement of cancer care.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to transform patient care by expanding access to data-driven medicine globally. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.com and connect with us on LinkedIn.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
Memorial Sloan Kettering (MSK) has institutional financial interests related to SOPHiA GENETICS.
Forward-Looking StatementsThis press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding SOPHiA GENETICS future results of operations and financial position, business strategy, products and technology, partnerships and collaborations, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on SOPHiA GENETICS' management's beliefs and assumptions and on information currently available to the company's management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in the company's filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of its date. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in the company's expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/leading-healthcare-institutions-adopt-msk-access-for-liquid-biopsy-testing-302383208.html
SOURCE SOPHiA GENETICS
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2025/24/c7219.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Is Micron (MU) the Next Big Winner in AI Memory? Analysts Think So
Micron Technology, Inc. (NASDAQ:MU) is one of the . On June 26, UBS raised the firm's price target on the stock to $155 from $120 and kept a 'Buy' rating on the shares. In a research note, the analyst told investors how Micron has delivered HBM revenue and gross margin that met or slightly exceeded investor expectations. 'MU delivered against the only real investor expectations we heard into the call – HBM [high bandwidth memory] revenue and gross margin, both of which were in-line to a little better than bogeys.' A close up of a circuit board, its microchips creating a powerful computing system. The company also boasts a strong financial position as demonstrated by its robust liquidity. With HBM becoming an important part of the DRAM business, it represents 6-7% of DRAM bits. However, they take up around 19-20% of production space as per UBS estimates, which is why Micron focuses on selling these chips to higher-value markets. UBS believes that the supply-constraint dynamics will stay until 2026, until Micron and its peers install new manufacturing capacity. The firm thinks this will be done 'carefully and strategically' in order to maintain favorable market conditions. Micron Technology, Inc. (NASDAQ:MU) develops and sells memory and storage products for data centers, mobile devices, and various industries worldwide. While we acknowledge the potential of MU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 AI Stocks in the Spotlight and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
2 Artificial Intelligence (AI) Stocks Worth Buying on the Next Dip
I'm waiting for SoundHound AI to boost its financials or for its stock price to come down. I prefer to buy Micron Technology during one of its predictable market downturns to maximize returns. Being patient and waiting for the right price can pay off, even in a hot market. 10 stocks we like better than SoundHound AI › The stock market has recovered from April's sudden dip. From the S&P 500 to the Nasdaq Composite, the market-defining indexes are reaching fresh all-time highs almost every day. As of June 27, those portfolios had gained 12.6% and 13.6%, respectively, over the last year. As a result, some of the best artificial intelligence (AI) stocks are running a bit hot again. I'm keeping a close eye on SoundHound AI (NASDAQ: SOUN) and Micron Technology (NASDAQ: MU) at the moment. Their stocks look a bit pricey today, but I'm ready to pounce on them in the next market dip. I've been a SoundHound AI fan for years, and I expect big things from this company in the long haul. Voice-control systems are gaining momentum in many different markets, from in-car controls and phone-based menu systems to drive-through windows and data center operations. SoundHound AI has been fine-tuning its AI-based voice interpretation tools since smartphones were new and hot. These days, the company offers agentic AI, process automation, and real-time conversations. The client list includes many of your favorite consumer electronics and carmaker brands. Their long-term contracts are starting to kick in, converting SoundHound AI's billion-dollar order backlog into actual revenues. Yet, I can't quite recommend this stock right now. SoundHound AI's shares posted artificial gains in a meme-stock moment in late 2024, and the peak prices are now long gone, but some lingering market effects remain. The stock is up 155% over the last 52 weeks, and it looked expensive at the start of that surge. So, one of two things must happen before I smash SoundHound AI's buy button again. The company could earn its lofty valuation by publishing dramatically stronger financials. Again, the beefy order backlog should generate lots of business over the next several years, but the revenue conversion process has been slow so far. The stock could take another haircut. This could happen over time as the meme stock mania fades out or very quickly alongside a downturn in the broader stock market. I don't mind waiting for SoundHound AI's business plan to gain traction. At the same time, this stock will be at the top of my list of buying ideas the next time every high-priced growth stock takes a big hit. Micron enters this discussion from a different angle. The memory chip giant's stock often trades at rock-bottom valuations, but it has been skyrocketing since April's tariff-based market dip. Mind you, the stock isn't exactly expensive even now. Micron's share price is up 95% from April's temporary market bottom, changing hands at a perfectly reasonable valuation of 22.8 times trailing earnings or 4.2 times sales. So, why am I waiting for another market correction? Why not grab a few shares at today's stock price, which looks pretty fair in the first place? Because I'm used to Micron trading at much lower valuation multiples. The company operates in a cyclical industry, tied to a mix of surprising and predictable shifts in the smartphone, data center, and PC markets. Micron investors have made a lot of money over the years by saving their buy-in cash for one of the seemingly inevitable downturns. That's the opposite of what's going on right now. Yes, Micron benefits from the general AI boom, partly thanks to a close partnership with AI accelerator leader Nvidia. Every number-crunching Nvidia Blackwell card comes with several dozen gigabytes of Micron's most advanced high-bandwidth memory (HBM). This close connection to the explosive AI opportunity could lift Micron's stock even higher. Call me a creature of habit; I'm just more comfortable waiting for the next price drop. Whether it springs from inflation fears or memory-chip price wars, you will almost certainly see one of those Micron buying windows open up in the next year or two. It's OK if I'm wrong, since my personal portfolio already holds a large helping of Micron stock. If I didn't have that advantage, I might consider buying a few shares at today's unusually high prices as well. Your mileage may vary, of course. I'd still save most of my cash for a rainy day around Micron's Idaho headquarters. Before you buy stock in SoundHound AI, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and SoundHound AI wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Anders Bylund has positions in Micron Technology, Nvidia, and SoundHound AI. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. 2 Artificial Intelligence (AI) Stocks Worth Buying on the Next Dip was originally published by The Motley Fool
Business Insider
43 minutes ago
- Business Insider
3 Economic Events That Could Affect Your Portfolio This Week, June 30 – July 4, 2025
Stocks surged, with the S&P 500 (SPX) and the tech-heavy Nasdaq-100 (NDX) reaching new records, rising 3.44% and 4.20%, respectively, for the week. After bouncing roughly 24% and 30% in less than three months, these indexes have now officially clocked in a V-shaped recovery. Meanwhile, the Dow Jones Industrial Average (DJIA) ended the weekly session with a gain of 3.82%, bringing its recovery from April's low to 19.7% and closing less than 3% below its all-time high. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Stocks hit these milestones thanks to strong investor enthusiasm for tech shares, particularly those in the AI sector, and rising hopes for a Fed rate cut later this year. The White House's announcement about signing a trade deal with China and the reveal of imminent plans to reach agreements with 10 major trading partners further jolted the markets. These developments overshadowed a dose of negativity from President Trump's abrupt termination of trade talks with Canada over its proposed digital services tax. Moreover, some good news also appeared on the macroeconomic front – particularly where it really matters for stocks – in forward-looking indicators. Although the Fed's preferred inflation gauge – core PCE – showed that price increases accelerated in May, the June consumer sentiment index jumped to a four-month high, as inflation expectations of U.S. households significantly improved. This mixed bag of data hasn't simplified the Fed's path to a rate-cut decision, with the governors seemingly in disagreement. Last week, Fed Chair Jerome Powell said he expects to see a pickup in inflation this summer and judged it best to continue with the 'wait and see' approach. Conversely, his colleagues Michelle Bowman and Chris Waller said they now see the central bank cutting rates as soon as July. Despite the unexpected resilience, the economy continues to gradually decelerate, with expenditures displaying weakness and unemployment expected to increase. U.S. stock markets will be closed on Friday, July 4, in observance of Independence Day. Three Economic Events Here are three key economic events that could affect your portfolio this week. For a full listing of additional economic reports, check out the TipRanks Economic Calendar. » June's ISM Manufacturing PMI – Tuesday, 07/01 – This report shows business conditions in the U.S. manufacturing sector and serves as a significant indicator of overall economic conditions. PMIs are considered one of the most reliable leading indicators for assessing the state of the U.S. economy, helping analysts and economists anticipate changing economic trends. » June's Nonfarm Payrolls and Unemployment Rate – Thursday, 07/03 – The Nonfarm Payrolls and Unemployment reports represent the number of new jobs created during the previous month, along with the percentage of people actively seeking employment in the previous month. These reports are two of the most important economic indicators, as the shift in the number of positions is strongly associated with the overall health of the economy. One of the Federal Reserve's mandates is full employment, and it considers labor market changes when determining its policy decisions. » June's ISM Services PMI – Thursday, 07/03 – This report reflects business conditions in the U.S. services sector, which contributes over 70% of the U.S. GDP. PMI indices are leading economic indicators used by economists and analysts to gain timely insights into changing economic conditions, as the direction and rate of change in the PMIs usually precede changes in the overall economy.
